Strong demographic demand, home equity growth, and favorable policy trends are driving steady mortgage insurance revenue and supporting future earnings potential, while enhanced technology and disciplined capital management are improving pricing accuracy, underwriting precision, and supporting shareholder returns through dividends and buybacks. The company has demonstrated strength in its balance sheet and continued confidence in long-term performance through aggressive capital allocation strategies.
Cyborg Score Rationale
Enact demonstrates strong market positioning in mortgage insurance with favorable demographic tailwinds and robust capital returns. The recent $500M buyback authorization combined with consistent dividends and analyst price target raises reflect investor confidence. However, analyst sentiment remains cautiously neutral, and the business remains sensitive to housing market conditions.
Top Insights
Enact is a leading provider of private mortgage insurance through its insurance subsidiaries.
The Board authorized a new $500 million share repurchase program in addition to a current $350 million program with $30 million remaining as of January 30, 2026.
Enact's diversification into the GSE credit risk transfer market and significant insurance in-force growth underscore its strategy for long-term profitability and expansion.
ACT exceeded both the U.S. Diversified Financial industry which returned -5.8% and the U.S. Market which returned 14.5% over the past year.
Named Competitors
Radian — Private mortgage insurance provider
Essent — Mortgage insurance and risk management services
NMI — Mortgage and specialty insurance products
Recent Developments
(February 2026) New $500 million share repurchase program authorized and quarterly dividend of $0.21 per share declared
(February 2026) Goldman Sachs raised price target to $50 from $45; strong 2025 results announced